15 min listen
Detecting Alzheimer’s Disease Early through a Blood Test
FromThe Bio Report
ratings:
Length:
25 minutes
Released:
Nov 15, 2023
Format:
Podcast episode
Description
One of the challenges with treating Alzheimer’s disease is diagnosing patients early enough in the course of its progression to have a meaningful impact with treatments. Sunbird Bio said it can accurately detect and differentiate specific proteins that aggregate and signal the presence of Alzheimer's disease, with a simple blood draw. It said its test in development could address the growing need for more sensitive, reliable, non-invasive diagnostic tests to accelerate drug development and enhance patient care. We spoke to John McDonough, executive chair and CEO of Sunbird Bio, about its diagnostic test for Alzheimer’s disease, how it has the potential to impact treatments and outcomes for millions of patients with the condition, and how its merger with Glympse Bio is expected to push it into new markets.
Released:
Nov 15, 2023
Format:
Podcast episode
Titles in the series (100)
A Look at the Year That Was in Biotech: The year 2014 was one for the record books for the biotech industry. In part one of a two-part podcast, we take a look back at the year that was with Adam Feuerstein, senior columnist for TheStreet.com. Feuerstein discusses the growing controversy ov... by The Bio Report